Manuel David
Martínez Bueno
Investigador en el periodo 2018-2021
Universidade de Lisboa
Lisboa, PortugalPublicaciones en colaboración con investigadores/as de Universidade de Lisboa (3)
2020
2019
-
Polymorphisms at phase I-metabolizing enzyme and hormone receptor loci influence the response to anti-TNF therapy in rheumatoid arthritis patients
Pharmacogenomics Journal, Vol. 19, Núm. 1, pp. 83-96
-
Steroid hormone-related polymorphisms associate with the development of bone erosions in rheumatoid arthritis and help to predict disease progression: Results from the REPAIR consortium
Scientific Reports, Vol. 9, Núm. 1